In November 2023, the FDA added BPC-157 to its list of substances that cannot be used in compounding under the Federal Food, Drug, and Cosmetic Act, citing insufficient safety data for human use 3
Research guides
A lack of clarity about who is responsible for implementation, funding, or monitoring can derail even the most promising projects
These growth factors stimulate tissue repair, reduce inflammation, and promote collagen production, addressing the root cause rather than just masking symptoms
Swelling, redness, or irritation of injection site
The supplement form offers a needle-free alternative for individuals seeking the proposed benefits without injectable administration, though the absence of human pharmacokinetic data limits dose precision